NEUROSTAR ADVANCED THERAPY
Report
- Report Number
- 3004824012-2022-00025
- Event Type
- Injury
- Date Received
- December 22, 2022
- Date of Event
- November 17, 2022
- Report Date
- December 22, 2022
- Manufacturer
- NEURONETICS, INC.
- Product Code
- OBP
- UDI-DI
- 00850005944522
- PMA / PMN Number
- K201158
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- PA, US
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
- Health Professional
- Yes
Narratives
THE INVESTIGATION INCLUDED A REVIEW OF THE PATIENT'S MEDICAL HISTORY AND CONCOMITANT MEDICATIONS. THE PATIENT WAS DIAGNOSED WITH ASPERGER'S SYNDROME WHICH MAY HAVE LOWERED HIS SEIZURE THRESHOLD. SEIZURE DISORDERS AND EPILEPSY ARE FREQUENTLY REPORTED COMORBIDITIES IN INDIVIDUALS WITH AUTISM SPECTRUM DISORDER WHICH INCLUDES THE SIGNS AND SYMPTOMS THAT WERE ONCE PART OF AN ASPERGER'S DIAGNOSIS. ADDITIONALLY, TWO OF THE MEDICATIONS THE PATIENT WAS TAKING (CLOMID AND AMPHETAMINE-DEXTROAMPHETAMINE) COULD ALSO POTENTIALLY LOWER HIS SEIZURE THRESHOLD.
NEURONETICS, INC. RECEIVED A CALL FROM A COMPANY REPRESENTATIVE THAT ONE OF HIS ACCOUNTS HAD A PATIENT WHO HAD A SEIZURE DURING HIS 10TH TMS TREATMENT SESSION. THE SEIZURE LASTED ONLY 2-3 MINUTES BUT THE PATIENT WAS TAKEN TO THE EMERGENCY ROOM AND HAD A CT SCAN WHICH WAS NORMAL. THE PATIENT WAS DISCHARGED THE SAME DAY AND HAS BEEN DOING WELL WITH NO VISIBLE LASTING ISSUES.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 2917121 | NEUROSTAR ADVANCED THERAPY | TRANSCRANIAL MAGNETIC STIMULATOR | OBP | NEURONETICS, INC. | NS 3.7 | 00850005944522 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 32 YR | Male | Other | AMPHETAMINE-DEXTROAMPHETAMINE 10MG BID (HOLDING)| ANASTROZOLE 1MG| ARMOUR THYROID 90MG IN AM| CLOMID 50MG 1/2 TABLET ONCE WEEKLY| LISINOPRIL 40MG| VERAPAMIL 40MG |